Austrian Biotech BIA Hits Ch. 15, Says Exec Stole $22M

Austrian biotechnology firm BIA has filed for Chapter 15 protection in Delaware to recover assets in the U.S., alleging an executive fraudulently transferred roughly $22 million in company funds and left it...

Already a subscriber? Click here to view full article